Oral Antiviral Treatments
Oral antiviral therapies Paxlovid (Pfizer), and molnupiravir (Merck) are products authorized by the FDA for treatment of COVID-19. These therapies require a prescription by a licensed and authorized provider. Patients should coordinate with their health care provider prior to contacting a location to receive these therapies.
What are Oral Antiviral Treatments?
The Food and Drug Administration (FDA) issued an emergency use authorization for molnupirvar by Merck and an emergency use authorization for Paxlovid™ by Pfizer as oral antiviral treatments of COVID-19. Early studies indicate these treatment options may reduce severe outcomes from COVID-19 including hospitalization or death. These treatments are recommended for individuals who are at high risk for progression to severe COVID-19 or have underlying medical conditions.
Where Are These Treatment Options Available?
The Tennessee Department of Health coordinated a distribution plan of molnupiravir and Paxlovid™ with Walmart pharmacies across the state. This medication is free, and Tennesseans can visit www.walmart.com/covidmedication to find a participating Walmart pharmacy near them.
These therapies require a prescription by a licensed and authorized provider. You should coordinate with your health care provider prior to contacting a location to receive these therapies.
For more information on Test-to-Treat locations please visit https://covid-19-test-to-treat-locator-dhhs.hub.arcgis.com/